Foghorn Therapeutics is down a bit on the day, funds flowing out kept the price down -1.56% since yesterday.
Foghorn Therapeutics doesn't seem to be at a very clear reversal point in either direction. Foghorn Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. FHTX might find some support at the 5.51 level, buyers might push the price back up from here. But it's not very clear what will happen.